T61 is a New Protein That Supports Retinal Axon Outgrowth and Regeneration
About the Research Project
Program
Award Type
Standard
Award Amount
$68,852
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
G2004035
Summary
Glaucoma can be viewed as a neurodegenerative disease in which retinal nerve cells degenerate. These nerve cells are responsible for carrying signals from the retina to the brain, and their loss results in blindness. A novel treatment for glaucoma would be to promote the regeneration of lost retinal nerve cells. Dr. Monnier has identified a protein (T61) that supports nerve growth, and its characterization represents an important step toward a molecular understanding of the environment that retinal nerve cells need in order to regenerate. Dr. Monnier believes that the lack of regeneration is due to the inhibitory factors in the environment of retinal nerve cells. He plans to first clone this protein, and then to perform a biochemical characterization and study its interaction with other proteins. He hopes to confirm the hypothesis that T61 supports retina nerve cell regeneration by showing that T61 allows nerve cell growth even in the presence of inhibitory factors that hamper regeneration. This is a long-term study that could have important consequences for the development of new treatments for glaucoma.
Related Grants
National Glaucoma Research
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Samuel Herberg, PhD
Current Organization
SUNY Upstate Medical University
How the Microenvironment Affects Schlemm’s Canal Cell Behavior
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Samuel Herberg, PhD
Current Organization
SUNY Upstate Medical University
National Glaucoma Research
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD
Current Organization
University of Virginia
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Xiaorong Liu, PhD
Current Organization
University of Virginia
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Diana C. Lozano, PhD
Current Organization
Oregon Health & Science University